Copyright Reports & Markets. All rights reserved.

Global Febuxostat Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Febuxostat

      • 1.1 Definition of Febuxostat
      • 1.2 Febuxostat Segment by Type
        • 1.2.1 Global Febuxostat Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 40mg
        • 1.2.3 80mg
        • 1.2.4 20mg
        • 1.2.5 120mg
      • 1.3 Febuxostat Segment by Applications
        • 1.3.1 Global Febuxostat Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Acute Gout
        • 1.3.3 Chronic Gout
      • 1.4 Global Febuxostat Overall Market
        • 1.4.1 Global Febuxostat Revenue (2014-2025)
        • 1.4.2 Global Febuxostat Production (2014-2025)
        • 1.4.3 North America Febuxostat Status and Prospect (2014-2025)
        • 1.4.4 Europe Febuxostat Status and Prospect (2014-2025)
        • 1.4.5 China Febuxostat Status and Prospect (2014-2025)
        • 1.4.6 Japan Febuxostat Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Febuxostat Status and Prospect (2014-2025)
        • 1.4.8 India Febuxostat Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Febuxostat
      • 2.3 Manufacturing Process Analysis of Febuxostat
      • 2.4 Industry Chain Structure of Febuxostat

      3 Development and Manufacturing Plants Analysis of Febuxostat

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Febuxostat Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Febuxostat
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Febuxostat Production and Capacity Analysis
      • 4.2 Febuxostat Revenue Analysis
      • 4.3 Febuxostat Price Analysis
      • 4.4 Market Concentration Degree

      5 Febuxostat Regional Market Analysis

      • 5.1 Febuxostat Production by Regions
        • 5.1.1 Global Febuxostat Production by Regions
        • 5.1.2 Global Febuxostat Revenue by Regions
      • 5.2 Febuxostat Consumption by Regions
      • 5.3 North America Febuxostat Market Analysis
        • 5.3.1 North America Febuxostat Production
        • 5.3.2 North America Febuxostat Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Febuxostat Import and Export
      • 5.4 Europe Febuxostat Market Analysis
        • 5.4.1 Europe Febuxostat Production
        • 5.4.2 Europe Febuxostat Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Febuxostat Import and Export
      • 5.5 China Febuxostat Market Analysis
        • 5.5.1 China Febuxostat Production
        • 5.5.2 China Febuxostat Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Febuxostat Import and Export
      • 5.6 Japan Febuxostat Market Analysis
        • 5.6.1 Japan Febuxostat Production
        • 5.6.2 Japan Febuxostat Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Febuxostat Import and Export
      • 5.7 Southeast Asia Febuxostat Market Analysis
        • 5.7.1 Southeast Asia Febuxostat Production
        • 5.7.2 Southeast Asia Febuxostat Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Febuxostat Import and Export
      • 5.8 India Febuxostat Market Analysis
        • 5.8.1 India Febuxostat Production
        • 5.8.2 India Febuxostat Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Febuxostat Import and Export

      6 Febuxostat Segment Market Analysis (by Type)

      • 6.1 Global Febuxostat Production by Type
      • 6.2 Global Febuxostat Revenue by Type
      • 6.3 Febuxostat Price by Type

      7 Febuxostat Segment Market Analysis (by Application)

      • 7.1 Global Febuxostat Consumption by Application
      • 7.2 Global Febuxostat Consumption Market Share by Application (2014-2019)

      8 Febuxostat Major Manufacturers Analysis

      • 8.1 Takeda Pharmaceuticals
        • 8.1.1 Takeda Pharmaceuticals Febuxostat Production Sites and Area Served
        • 8.1.2 Takeda Pharmaceuticals Product Introduction, Application and Specification
        • 8.1.3 Takeda Pharmaceuticals Febuxostat Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 MACLEODS
        • 8.2.1 MACLEODS Febuxostat Production Sites and Area Served
        • 8.2.2 MACLEODS Product Introduction, Application and Specification
        • 8.2.3 MACLEODS Febuxostat Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Prinston Pharmaceutical
        • 8.3.1 Prinston Pharmaceutical Febuxostat Production Sites and Area Served
        • 8.3.2 Prinston Pharmaceutical Product Introduction, Application and Specification
        • 8.3.3 Prinston Pharmaceutical Febuxostat Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Alembic Pharmaceuticals
        • 8.4.1 Alembic Pharmaceuticals Febuxostat Production Sites and Area Served
        • 8.4.2 Alembic Pharmaceuticals Product Introduction, Application and Specification
        • 8.4.3 Alembic Pharmaceuticals Febuxostat Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Hikma Pharmaceuticals
        • 8.5.1 Hikma Pharmaceuticals Febuxostat Production Sites and Area Served
        • 8.5.2 Hikma Pharmaceuticals Product Introduction, Application and Specification
        • 8.5.3 Hikma Pharmaceuticals Febuxostat Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Lupin Limited
        • 8.6.1 Lupin Limited Febuxostat Production Sites and Area Served
        • 8.6.2 Lupin Limited Product Introduction, Application and Specification
        • 8.6.3 Lupin Limited Febuxostat Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Mylan
        • 8.7.1 Mylan Febuxostat Production Sites and Area Served
        • 8.7.2 Mylan Product Introduction, Application and Specification
        • 8.7.3 Mylan Febuxostat Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Teijin Pharma
        • 8.8.1 Teijin Pharma Febuxostat Production Sites and Area Served
        • 8.8.2 Teijin Pharma Product Introduction, Application and Specification
        • 8.8.3 Teijin Pharma Febuxostat Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Hengrui Pharma
        • 8.9.1 Hengrui Pharma Febuxostat Production Sites and Area Served
        • 8.9.2 Hengrui Pharma Product Introduction, Application and Specification
        • 8.9.3 Hengrui Pharma Febuxostat Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Sun Pharma
        • 8.10.1 Sun Pharma Febuxostat Production Sites and Area Served
        • 8.10.2 Sun Pharma Product Introduction, Application and Specification
        • 8.10.3 Sun Pharma Febuxostat Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Febuxostat Market

      • 9.1 Global Febuxostat Market Trend Analysis
        • 9.1.1 Global Febuxostat Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Febuxostat Regional Market Trend
        • 9.2.1 North America Febuxostat Forecast 2019-2025
        • 9.2.2 Europe Febuxostat Forecast 2019-2025
        • 9.2.3 China Febuxostat Forecast 2019-2025
        • 9.2.4 Japan Febuxostat Forecast 2019-2025
        • 9.2.5 Southeast Asia Febuxostat Forecast 2019-2025
        • 9.2.6 India Febuxostat Forecast 2019-2025
      • 9.3 Febuxostat Market Trend (Product Type)
      • 9.4 Febuxostat Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Febuxostat Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Febuxostat can effectively reduce the risk of gout and hyperuricemia by stably controlling the patient's uric acid value.
        Febuxostat is a uric acid production inhibitor. It is an activity that can hinder the production of blood uric acid in the body - xanthine oxidase. Then the body normally metabolizes excess uric acid from the body. Therefore, it will not increase the burden of liver and kidney, and patients with low liver and kidney function can also take this drug conveniently.

        The global Febuxostat market was valued at 850 million US$ in 2018 and will reach 2020 million US$ by the end of 2025, growing at a CAGR of 11.4% during 2019-2025.
        This report focuses on Febuxostat volume and value at global level, regional level and company level. From a global perspective, this report represents overall Febuxostat market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Febuxostat in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Febuxostat manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Takeda Pharmaceuticals
        MACLEODS
        Prinston Pharmaceutical
        Alembic Pharmaceuticals
        Hikma Pharmaceuticals
        Lupin Limited
        Mylan
        Teijin Pharma
        Hengrui Pharma
        Sun Pharma

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        40mg
        80mg
        20mg
        120mg

        Segment by Application
        Acute Gout
        Chronic Gout

        Buy now